Добірка наукової літератури з теми "RHDV"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "RHDV".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "RHDV"
Fitzner, Andrzej, and Wiesław Niedbalski. "Diversity of RHD virus: epidemiological, diagnostic and immunological importance." Medycyna Weterynaryjna 73, no. 12 (2017): 811–18. http://dx.doi.org/10.21521/mw.5815.
Повний текст джерелаReemers, Sylvia, Leon Peeters, Joyce van Schijndel, Beth Bruton, David Sutton, Leo van der Waart, and Saskia van de Zande. "Novel Trivalent Vectored Vaccine for Control of Myxomatosis and Disease Caused by Classical and a New Genotype of Rabbit Haemorrhagic Disease Virus." Vaccines 8, no. 3 (August 5, 2020): 441. http://dx.doi.org/10.3390/vaccines8030441.
Повний текст джерелаAbade dos Santos, Fábio A., Carolina Magro, Carina L. Carvalho, Pedro Ruivo, Margarida D. Duarte, and Maria C. Peleteiro. "A Potential Atypical Case of Rabbit Haemorrhagic Disease in a Dwarf Rabbit." Animals 11, no. 1 (December 28, 2020): 40. http://dx.doi.org/10.3390/ani11010040.
Повний текст джерелаCapucci, Lorenzo, Patrizia Cavadini, and Antonio Lavazza. "Viral haemorrhagic disease: RHDV type 2 ten years later." World Rabbit Science 30, no. 1 (March 31, 2022): 1–11. http://dx.doi.org/10.4995/wrs.2022.16505.
Повний текст джерелаMagouz, A. F., E. A. Elsayed, and A. Y. Metwally. "Detection and characterisation of rabbit haemorrhagic disease virus strains circulating in Egypt." BULGARIAN JOURNAL OF VETERINARY MEDICINE 22, no. 4 (2019): 409–18. http://dx.doi.org/10.15547/bjvm.2085.
Повний текст джерелаSaidi, Aissa, and Abdelouahed Aboutaib. "Confirmation of the Rabbit Hemorrhagic Disease Virus Type 2 (GI.2) Circulation in North Africa." Acta Veterinaria 72, no. 4 (December 1, 2022): 433–41. http://dx.doi.org/10.2478/acve-2022-0035.
Повний текст джерелаABD EL-GHANY, WAFAA A. "A Review on Rabbit Hemorrhagic Disease with a Special Reference to Egyptian Situation." Journal of the Hellenic Veterinary Medical Society 71, no. 3 (October 15, 2020): 2243. http://dx.doi.org/10.12681/jhvms.25065.
Повний текст джерелаRosell, Joan M., L. Fernando de la Fuente, Francisco Parra, Kevin P. Dalton, J. Ignacio Badiola Sáiz, Ana Pérez de Rozas, Juan J. Badiola Díez, et al. "Myxomatosis and Rabbit Haemorrhagic Disease: A 30-Year Study of the Occurrence on Commercial Farms in Spain." Animals 9, no. 10 (October 10, 2019): 780. http://dx.doi.org/10.3390/ani9100780.
Повний текст джерелаFitzner, Andrzej. "Evaluation of the usefulness of laboratory diagnostic methods in RHD outbreak." Bulletin of the Veterinary Institute in Pulawy 58, no. 2 (June 1, 2014): 177–86. http://dx.doi.org/10.2478/bvip-2014-0027.
Повний текст джерелаHall, Robyn N., Tegan King, Tiffany W. O’Connor, Andrew J. Read, Sylvia Vrankovic, Melissa Piper, and Tanja Strive. "Passive Immunisation against RHDV2 Induces Protection against Disease but Not Infection." Vaccines 9, no. 10 (October 18, 2021): 1197. http://dx.doi.org/10.3390/vaccines9101197.
Повний текст джерелаДисертації з теми "RHDV"
Marsh, Maija. "The effect of behaviour in disease transmission : Understanding RHDV Dynamics in Austrlian rabbit populations." Thesis, University of York, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520028.
Повний текст джерелаFages, Marie-Philippe Bertagnoli Stéphane. "Identification d'un nouveau variant apathogène du virus de la maladie hémorragique virale du lapin (RHDV)." [S.l.] : [s.n.], 2007. http://oatao.univ-toulouse.fr/1755/1/debouch_1755.pdf.
Повний текст джерелаJoubert, Pascale. "Etude des mécanismes de maturation de la polyprotéine du virus de la maladie hémorragique du lapin (RHDV)." Tours, 2000. http://www.theses.fr/2000TOUR4009.
Повний текст джерелаNo summary available
Müller, Claudia [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "A new RHDV-2 vaccine based on recombinant baculovirus : generation and characterization of induced immunity in rabbits / Claudia Müller ; Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2018. http://d-nb.info/1158496206/34.
Повний текст джерелаGuillon, Patrice. "Antigènes tissulaires de groupe sanguin ABH acteurs de la protection innée antivirale : exemples des Calicivirus (NV et RHDV) et du Coronavirus SRAS-CoV." Nantes, 2008. https://archive.bu.univ-nantes.fr/pollux/show/show?id=d7627fae-7b41-4797-ad78-963bffc5f6c7.
Повний текст джерелаHisto-blood group antigens are glycan motifs present on mammalian epithelial surfaces and in secretion. They are also found on erythrocytes from apes. Their synthesis requires glycosyltransferases encoded by the Futi, Fut2, Seel and Abo genes. They are ligands for various Calicivirus strains of the norovirus genus which cause gastroenteritis in humans and polymorphisms at the FUT2 and ABO loci control sensitivity to these viruses. In this work, we show that maternal milk contains mucin-type molecules that inhibit NV strain binding to its α1,2fucosylated ligand. The inhibition depends upon a FUT2 allele that allows α1,2fucosylation. Another Calicivirus, RHDV, responsible for the rabbit hemorrhagic disease, binds to an α1,2fucosylated ligand. We observed that there exist wild rabbits presenting a deficit of expression of the ligand. Their frequency is increased following RHD outbreaks. Moreover, a Seel allele has been associated with the survival of animals, suggesting a selection by the virus. The enveloppe protein of the SARS Coronavirus allows binding to its cellular receptor and may carry ABH antigens. We show that natural antibodies from the plasma of 0 individuals inhibit attachment of this protein to its receptor when it is synthesized in A cells. This may explain the higher sensitivity of A (or B) individuals to SARS. Overall, the results are discussed to suggest that histo-blood group antigens could contribute to innate antivirus protection by various complementary mechanisms, which could explain why they have been maintained throughout mammalian evolution
Müller, Alexandra. "Virus-host adatation and co-evolution of myxoma virus (MV) and rabbit haemorrhagic disease virus (RHDV) in their natural host, the wild rabbit (oryctolagus cuniculus)." Doctoral thesis, Instituto de Ciências Biomédicas Abel Salazar, 2009. http://hdl.handle.net/10216/45396.
Повний текст джерелаMüller, Alexandra. "Virus-host adatation and co-evolution of myxoma virus (MV) and rabbit haemorrhagic disease virus (RHDV) in their natural host, the wild rabbit (oryctolagus cuniculus)." Tese, Instituto de Ciências Biomédicas Abel Salazar, 2009. http://hdl.handle.net/10216/45396.
Повний текст джерелаLe, Gall Ghislaine. "Calicivirus des lagomorphes : détermination de la séquence nucléotidique de l'EBHSV (european brown hare syndrome virus) : épidémiologie moléculaire des virus EBHSV et RHDV(rabbit haemorrhagic disease virus)." Brest, 1997. http://www.theses.fr/1997BRES3103.
Повний текст джерелаLaurent, Sylvie. "Étude de la protéine de capside des calicivirus des lagomorphes RHDV (Rabbit Haemorrhagic Disease Virus) et EBHSV (European Brown Hare Syndrome Virus) : antigénicité, vaccination et assemblage." Compiègne, 1997. http://www.theses.fr/1997COMP1029.
Повний текст джерелаRodrigues, Artemis Socorro do Nascimento. "Caracterização molecular dos antigenos RhD, (RhD fraco e RhD parcial) e sua aplicação na pratica transfusional." [s.n.], 2005. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310418.
Повний текст джерелаTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-04T11:27:19Z (GMT). No. of bitstreams: 1 Rodrigues_ArtemisSocorrodoNascimento_D.pdf: 9543028 bytes, checksum: 5774a3716484ea2212070f20c266a89f (MD5) Previous issue date: 2005
Resumo: Considerando a imunogenicidade e importância clínica do antígeno RhD bem como o grande número de variantes RhD identificadas, estudos que possam esclarecer sua expressão e mecanismos moleculares envolvidos são importantes para a padronização de técnicas moleculares e sorológicas em diferentes populações. Assim foram nossos objetivos: padronizar técnicas moleculares para realização da genotipagem RHD fraco e determinar sua ocorrência na população brasileira; associar os tipos de RhD fracos encontrados com os haplótipos Rh presentes; e avaliar a aplicação da determinação do antígeno RhD na prática transfusional. Estudamos 503 amostras de DNA de doadores voluntários de sangue fenotipados como RhD ftaco. Destas amostras de DNA estudadas, 415 (82,5%) foram caracterizadas como RhD ftaco, 65 (12,9%) como RhD parcial, 15 (3%) apresentaram associações de RhD parcial e RhD ftaco e 8 (1,6%) foram RhD normal. I Os antígenos RhD fraco tipos 1, 3 e 4 foram os mais fteqüentes em nossa população. Como estes três tipos de RhD fraco não apresentam risco de aloimunização anti-D, pacientes assim classificadospodem ser transfundidos com sangue RhD-positivo. Nossos resultados demonstraram que 12,~A>das amostras fenotipadas como RhD fraco eram na verdade RhD parcial. Os antígenos RhD parciais encontrados em nosso estudo foram D~ DHMi e DVI. Quarenta (7,9%) amostras de DNA foram caracterizadas como D~ 16 (3,2%) como DHMi e 9 (1,8%) como DVI. A caracterização dos antígenos RhD parciais que reagem sorologicamente como RhD ftaco, tais como D DHMi e RhD categoria VI pode ser de grande auxilio na prevenção da aloimunização anti-D em pacientes politransfundidos e gestantes. A freqüência dos antígenos RhD parciais D~ DHMi e DVI encontrada em nossas amostras sugere um elevado risco de aloimunização ao antígeno RhD em pacientes fenotipados como RhD ftaco. - Das 503 amostras estudadas, 15 apresentaram mutações responsáveis pela expressão do antígeno RhD fraco e ao mesmo tempo mutações características de antígenos RhD parciais, ou seja, estas amostras possuíam os antígenos RhD fraco e RhD parcial associados. Estudamos quatro amostras de DNA de pacientes fenotipados como RhD :fraco que apresentavam anti-D. Nosso estudo demonstrou que a aloimunização anti-D nestes pacientes estava relacionada à presença de um antígeno RhD parcial e não a um antígeno RhD :fraco como diagnosticado sorologicamente. Duas amostras foram classificadascomo RhD parcial DAR, 1 como RhD parcial DHMi e 1 como DVI. Os resuhados demonstraram que os tipos de RhD fraco 1, 2, 3 e 4 que foram detectados à TA ou à 3'te e apresentaram grau de aglutinação superior a 1+ na AGH podem ser considerados como RhD positivo, pois não foram associados ao antígeno RhD parcial. Apesar deste trabalho ter sido o único que relacionou os tipos de RhD ftaco com o grau de aglutinação, a literatura revela que ainda não foi demonstrada aloimunização anti-D em pacientes portadores dos antígenos RhD fraco tipos 1,2 e 3. De acordo com os nossos resultados pode-se concluir que: 1. A transfusão com sangue RhD-positivo pode ser recomendada para todos os pacientes que apresentam os tipos do antígeno RhD :ftaco 1, 3 e 4 identificados por técnicas moleculares e para aqueles que apresentarem grau de aglutinação superior a 1+ na fenotipagem RhD. 2. A utilização de métodos de fenotipagem mais sensíveis em combinação com reagentes anti-D de alta afinidade é recomendada na detecção de antígenos RhD ftaco com baixa densidade antigênica em doadores de sangue; 3. Há necessidade da utilização de dois anti-soros monoc1onais (IgM e IgG) na determinação do antígeno RhD :ftacoem pacientes; 4. As genotipagens RHD, RHD ftaco e RHD parcial devem ser rea1i73dasquando os resuhados sorológicos não forem claros ou quando o paciente for politransfundido. 5. A biologia molecular associada à hemaglutinação pode aumentar consideravelmente a segurança transfusional pela mellior caracterização dos antígenos RhD em nossa população
Abstract: The purpose of this study was to characterize by molecular studies theRhD antigens (weak D and partial D) in Brazilian blood donors. DNA samples ftom 503 blood donors phenotyped as weak D were tested by two different sequence-specific primers (pCR-SSP) assays to determine the presence or absence of RHD gene (PCR-SSP intron 4 and exon 10) and to detect the common weak D types. Ofthe 503 weak D samples studied, 415 (82,5%) were identified as weak D, 65 (12,9%) as partial D, 15 (3%) showed association ofweak D and partial D and 8 (1,6%) were normal D. Weak D types 1, 3 and 4 contributed more than 85% of alI molecular weak D types. For these 3 types, D-positive transfusion can be considered safe because no immunization events have been documented yet. These findings show for the first time the frequency of weak D types in Brazilians. Molecular analysis showed that 12,9% of the weak D phenotype samples studied carried a partia! D alIele. The partial Ds found in our study were DAR, DVI and DHMi. Forty (7,9%) DNA samples were characterized as DAR, 16 (3,8%) as DHMi and 9 (1,8%) as DVI. The characterization of the partia! D antigens DAR, DHMi and DVI may avoid alIoimmunization in patients phenotyped as weak D. Fiffeteen patients showed mutations to weak D and partia! D showing that these samples had the weak D and partia! D antigens associated. We also studied 4 DNA samples of patients phenotyped as weak D who had developed anti-D. Our study showed that anti-D alIoimmunization in these patients was associated with the presence of partia! D antigens. Two samples were classified as partia!, D DAR, 1 as DHMi and 1 was DVI.AlI the weak D types identified in our study were associated with the intensity of agglutination obtained at room temperature (RT), 3'fC and AGH. The sensitivity of detecting weak D depends on the anti-D reagent and on the exact conditions of the methods. Our results showed that the weak D types 1, 2, 3 and 4 were frequently detected at RT and 3'fC and therefore could be considered as D-positive for transfusion. According to our results we could recommend the use ofmonoclonal anti-DIgM with high avidity to detect weak D antigen with low antigen density in blood donors and two monoclonals, one IgM and one IgG in combination with AGT to detect the weak D antigen in patients
Doutorado
Ciencias Basicas
Doutor em Clínica Médica
Книги з теми "RHDV"
Matheson, Kimberly. Functional characterization of the RHD promoter. Ottawa: National Library of Canada, 2002.
Знайти повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. Heart Rate Variability Analysis with the R package RHRV. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6.
Повний текст джерелаPHELPS. STUDYING DIVERSE LIVES RHD V3#4. Lawrence Erlbaum, 2007.
Знайти повний текст джерелаConstantino Antonio Antonio García García Martínez, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. Heart Rate Variability Analysis with the R package RHRV. Springer, 2017.
Знайти повний текст джерелаHeloisa Nascimento Beserra, Ana. NOÇÕES BÁSICAS DE ALOIMUNIZAÇÃO RhD Na gestação. EDITORA CRV, 2015. http://dx.doi.org/10.24824/978854440633.5.
Повний текст джерелаRoy, Kevin M. Second Chances As Transformative Stories Rhd V3 2&3. Taylor & Francis Group, 2015.
Знайти повний текст джерелаRoy, Kevin M. Second Chances As Transformative Stories Rhd V3 2&3. Taylor & Francis Group, 2015.
Знайти повний текст джерелаRoy, Kevin M. Second Chances As Transformative Stories Rhd V3 2&3. Taylor & Francis Group, 2015.
Знайти повний текст джерелаRoy, Kevin M. Second Chances As Transformative Stories Rhd V3 2&3. Taylor & Francis Group, 2015.
Знайти повний текст джерелаAntonucci, Toni C. Immigration Adaptation and Well Being Across Rhd V2#4. Taylor & Francis Group, 2016.
Знайти повний текст джерелаЧастини книг з теми "RHDV"
Lavazza, Antonio, and Lorenzo Capucci. "How Many Caliciviruses are there in Rabbits? A Review on RHDV and Correlated Viruses." In Lagomorph Biology, 263–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-72446-9_18.
Повний текст джерелаPoisson, Jessica. "RhD Compatibility." In Transfusion Management of the Obstetrical Patient, 103–6. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-77140-3_12.
Повний текст джерелаKato, Shoji, and Jun Fukue. "Astrophysical RHD Flows." In Astronomy and Astrophysics Library, 445–76. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4174-2_22.
Повний текст джерелаClausen, Frederik Banch, Klaus Rieneck, Grethe Risum Krog, Birgitte Suhr Bundgaard, and Morten Hanefeld Dziegiel. "Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis." In Prenatal Diagnosis, 347–59. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8889-1_23.
Повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. "Introduction to Heart Rate Variability." In Heart Rate Variability Analysis with the R package RHRV, 1–14. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6_1.
Повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. "Loading, Plotting, and Filtering RR Intervals." In Heart Rate Variability Analysis with the R package RHRV, 15–28. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6_2.
Повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. "Time-Domain Analysis." In Heart Rate Variability Analysis with the R package RHRV, 29–36. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6_3.
Повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. "Frequency Domain Analysis." In Heart Rate Variability Analysis with the R package RHRV, 37–68. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6_4.
Повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. "Nonlinear and Fractal Analysis." In Heart Rate Variability Analysis with the R package RHRV, 69–116. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6_5.
Повний текст джерелаGarcía Martínez, Constantino Antonio, Abraham Otero Quintana, Xosé A. Vila, María José Lado Touriño, Leandro Rodríguez-Liñares, Jesús María Rodríguez Presedo, and Arturo José Méndez Penín. "Comparing HRV Variability Across Different Segments of a Recording." In Heart Rate Variability Analysis with the R package RHRV, 117–32. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65355-6_6.
Повний текст джерелаТези доповідей конференцій з теми "RHDV"
Guo, Zhen, Yuan Wang, Qian Yu, Jie Xiao, Kaiyu Liu, Ying Wang, Auguste Commeyras, and Yi Li. "Notice of Retraction: Construction of Recombinant Rabbit Hemorrhagic Disease Virus (RHDV) Vaccine Using Myxoma Virus (MV) as a Vector." In 2011 5th International Conference on Bioinformatics and Biomedical Engineering. IEEE, 2011. http://dx.doi.org/10.1109/icbbe.2011.5781650.
Повний текст джерелаClark, R. P., and C. P. Brown. "Selection of Descent and Ascent Method for the WHOI RHOV." In SNAME Maritime Convention. SNAME, 2008. http://dx.doi.org/10.5957/smc-2008-014.
Повний текст джерелаManjula, M., M. Sundareswari, D. S. Jayalakshmi, and E. Viswanathan. "Theoretical investigation on improving the ductility of Rh3V by ternary addition." In NANOFORUM 2014. AIP Publishing LLC, 2015. http://dx.doi.org/10.1063/1.4918026.
Повний текст джерелаSoranna, Francesco, Yi-Chih Chow, Oguz Uzol, and Joseph Katz. "Flow Structure and Turbulence in the Tip Region of a Turbomachine Rotor Blade." In ASME Turbo Expo 2007: Power for Land, Sea, and Air. ASMEDC, 2007. http://dx.doi.org/10.1115/gt2007-27590.
Повний текст джерелаShahzad, Mian M., Ligegowda S. Mangala, Jeong W. Lee, Koji Matsuo, Maya P. Nair, Hee D. Han, Edna M. Mora, et al. "Abstract 5517: Targeting anticancer therapeutics: A role for reconstituted high density lipoprotein (rHDL)." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5517.
Повний текст джерелаYang, Jing, Taariq Salie, Carlos R. Ramírez Medina, Simon Frain, Nophar Geifman, Anthony Whetton, Mark Engel, and Bernard Keavney. "47 Data independent acquisition mass spectrometry in severe rheumatic heart disease (rhd) identifies a proteomic signature showing ongoing inflammation and effectively classifying rhd cases." In British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, 6–8 June 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bcs.47.
Повний текст джерелаYang, Jing, Taariq Salie, Carlos R. Ramírez Medina, Simon Frain, Nophar Geifman, Anthony Whetton, Mark Engel, and Bernard Keavney. "47 Data independent acquisition mass spectrometry in severe rheumatic heart disease (rhd) identifies a proteomic signature showing ongoing inflammation and effectively classifying rhd cases." In British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, 6–8 June 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bcs.47.
Повний текст джерелаYANG, Zexiao, Yadong LIU, Zhengqun MENG, Bo WANG, Xueping YAO, Yin WANG, Yi GENG, and Yan LI. "Preliminary Study on The SYBR Green I RT- qPCR for Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Detection." In International Conference on Biological Engineering and Pharmacy 2016 (BEP 2016). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/bep-16.2017.9.
Повний текст джерелаRikken, Maarten, Daan Tjepkema, Rupert Gibson, and David Gration. "Refurbishment of orthotropic steel decks with steel plates." In IABSE Congress, Ghent 2021: Structural Engineering for Future Societal Needs. Zurich, Switzerland: International Association for Bridge and Structural Engineering (IABSE), 2021. http://dx.doi.org/10.2749/ghent.2021.1496.
Повний текст джерелаRikken, Maarten, Daan Tjepkema, Rupert Gibson, and David Gration. "Refurbishment of orthotropic steel decks with steel plates." In IABSE Congress, Ghent 2021: Structural Engineering for Future Societal Needs. Zurich, Switzerland: International Association for Bridge and Structural Engineering (IABSE), 2021. http://dx.doi.org/10.2749/ghent.2021.1496.
Повний текст джерелаЗвіти організацій з теми "RHDV"
Anninos, P. Kull ALE: I. Unstructured Mesh Advection, Interface Capturing, and Multiphase 2T RHD with Material Interfaces. Office of Scientific and Technical Information (OSTI), February 2002. http://dx.doi.org/10.2172/15006516.
Повний текст джерела